Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

Deciphering the Molecular Mechanisms Mediating Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) with Patient-Derived Kidney Organoids

FY 2024-25

Summary
Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) is a rare autosomal-recessive disorder caused by mutations in the SLC34A3 gene, which encodes the sodium-phosphate co-transporter NaPi2C. Together with NaPi2A (encoded by SLC34A1), these transporters are critical to phosphate reabsorption from the kidney proximal tubule. HHRH is characterized by renal phosphate wasting, hypophosphatemia, and hypercalciuria, leading to bony abnormalities and kidney stones. A novel SLC34A3 mutation, c.1248_1249del, was identified, and found to render NaPi2C nonfunctional.This research aims to investigate why the homologous transporter NaPi2A does not compensate for NaPi2C loss of function, and why heterozygous carriers of this variant unexpectedly display a partial disease phenotype. We hypothesize that the mutant NaPi2C protein interacts with wild-type NaPi2A and NaPi2C, disrupting their function. Single-cell models have been limited in replicating the kidney complex proximal tubule environment, necessitating more physiologically relevant systems.To address this, we will develop kidney organoids from patient-derived induced pluripotent stem cells (iPSCs). These organoids mimic kidney development and function, allowing the study of protein expression, localization, and phosphate transport. We will validate SLC34A1 and A3 expression via qPCR and Western Blot, assess subcellular localization by confocal microscopy, and quantify phosphate uptake using radio isotopes. Additionally, CRISPR-Cas9 gene-editing will restore wild-type SLC34A3 in patient iPSCs to evaluate functional rescue.This study will elucidate the molecular mechanisms underlying HHRH and expand our understanding of phosphate homeostasis, paving the way for potential therapeutic interventions.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530043
Name
Muldrew Nellie
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deciphering the Molecular Mechanisms Mediating Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) with Patient-Derived Kidney Organoids
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Hereditary Hypophosphatemic Rickets With Hypercalciuria; Induced Pluripotent Stem Cells; Kidney Organoids; Napi2a; Napi2c; Phosphate Homeostasis; Protein Interactions; Proximal Tubule; Renal Physiology; Slc34a3
Abstract
Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) is a rare autosomal-recessive disorder caused by mutations in the SLC34A3 gene, which encodes the sodium-phosphate co-transporter NaPi2C. Together with NaPi2A (encoded by SLC34A1), these transporters are critical to phosphate reabsorption from the kidney proximal tubule. HHRH is characterized by renal phosphate wasting, hypophosphatemia, and hypercalciuria, leading to bony abnormalities and kidney stones. A novel SLC34A3 mutation, c.1248_1249del, was identified, and found to render NaPi2C nonfunctional.This research aims to investigate why the homologous transporter NaPi2A does not compensate for NaPi2C loss of function, and why heterozygous carriers of this variant unexpectedly display a partial disease phenotype. We hypothesize that the mutant NaPi2C protein interacts with wild-type NaPi2A and NaPi2C, disrupting their function. Single-cell models have been limited in replicating the kidney complex proximal tubule environment, necessitating more physiologically relevant systems.To address this, we will develop kidney organoids from patient-derived induced pluripotent stem cells (iPSCs). These organoids mimic kidney development and function, allowing the study of protein expression, localization, and phosphate transport. We will validate SLC34A1 and A3 expression via qPCR and Western Blot, assess subcellular localization by confocal microscopy, and quantify phosphate uptake using radio isotopes. Additionally, CRISPR-Cas9 gene-editing will restore wild-type SLC34A3 in patient iPSCs to evaluate functional rescue.This study will elucidate the molecular mechanisms underlying HHRH and expand our understanding of phosphate homeostasis, paving the way for potential therapeutic interventions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Muldrew, Nellie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~